EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exacerbation of financial burden of insulin and overall glucose‐lowing medications among uninsured population with diabetes

Yilu Lin iD, Hui Shao, Vivian Fonseca, Lizheng Shi

Journal of Diabetes · 2023-03 · 15 (3) · 215-223

DOI: 10.1111/1753-0407.13360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 07.02.2023. Verfasst von Yilu Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy and Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, United States. Hauptthemen laut MEDLINE: Medically Uninsured, Diabetes Mellitus. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 7.4 million Americans with diabetes used insulin. This study aimed to document the 10‐year trend of insulin and other glucose‐lowering medications expenditure among insured and uninsured populations and to examine the impact of insulin out‐of‐pocket (OOP) payment and insurance status on glucose‐lowering medication OOP expenditure.

Methods

We extracted data from the Medical Expenditure Panel Survey (2009–2018) to document trends in the expenditure of insulin among people with diabetes. Total expenditures and OOP spending per person were documented on insulin and noninsulin glucose‐lowering medications among insured and uninsured populations. Multivariable regression was applied to assess the association of insulin OOP payment and insurance status on glucose‐lowering medication OOP expenditure.

Results

Although insulin usage was stable over the decades, total insulin expenditure almost doubled per person per year after the Affordable Care Act (ACA) regardless of the insurance status. The OOP cost of insulin by the uninsured population increased from $1678 per person per year in the pre‐ACA period to $2800 per person per year in the post‐ACA period. After the ACA was enacted, the uninsured population had $403.96 and $143.64 more on OOP costs than the people with public and private insurance, respectively.

Conclusion

For insured people, the rising financial burden of insulin was borne mainly by insurance. The uninsured population is bearing a heavy burden due to the high price of insulin. Policymakers should take action to reduce the insulin price and improve the transparency of the insulin pricing process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medically UninsuredDiabetes MellitusHumansUnited StatesInsulinPatient Protection and Affordable Care ActFinancial StressHealth Expenditures

Stichwörter der Autor:innen

financial burdeninsulinuninsured无保险胰岛素财务负担

Substanzen

Insulin

Autor:innen und Institutionen

  • Department of Health Policy and Management, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, United States.
  • Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, United States.
  • Department of Medicine and Pharmacology, School of Medicine, Tulane University, New Orleans, Louisiana, United States.

ORCID-Profile: Yilu Lin

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Lin, Y., Shao, H., Fonseca, V., & Shi, L. (2023). Exacerbation of financial burden of insulin and overall glucose‐lowing medications among uninsured population with diabetes. Journal of Diabetes, 15(3), 215-223. https://doi.org/10.1111/1753-0407.13360

Vancouver

Lin Y, Shao H, Fonseca V, Shi L. Exacerbation of financial burden of insulin and overall glucose‐lowing medications among uninsured population with diabetes. Journal of Diabetes. 2023;15(3):215-223. doi:10.1111/1753-0407.13360

BibTeX
@article{Lin2023,
  author = {Lin, Yilu and Shao, Hui and Fonseca, Vivian and Shi, Lizheng},
  title = {Exacerbation of financial burden of insulin and overall glucose‐lowing medications among uninsured population with diabetes},
  journal = {Journal of Diabetes},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {215--223},
  doi = {10.1111/1753-0407.13360}
}
Kostenlos starten →